1. Home
  2. HALO vs KT Comparison

HALO vs KT Comparison

Compare HALO & KT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • KT
  • Stock Information
  • Founded
  • HALO 1998
  • KT 1981
  • Country
  • HALO United States
  • KT South Korea
  • Employees
  • HALO N/A
  • KT N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • KT Telecommunications Equipment
  • Sector
  • HALO Health Care
  • KT Telecommunications
  • Exchange
  • HALO Nasdaq
  • KT Nasdaq
  • Market Cap
  • HALO 7.6B
  • KT 8.6B
  • IPO Year
  • HALO N/A
  • KT 1999
  • Fundamental
  • Price
  • HALO $73.13
  • KT $18.29
  • Analyst Decision
  • HALO Buy
  • KT
  • Analyst Count
  • HALO 12
  • KT 0
  • Target Price
  • HALO $73.33
  • KT N/A
  • AVG Volume (30 Days)
  • HALO 2.7M
  • KT 1.6M
  • Earning Date
  • HALO 11-03-2025
  • KT 11-11-2025
  • Dividend Yield
  • HALO N/A
  • KT 3.59%
  • EPS Growth
  • HALO 56.68
  • KT N/A
  • EPS
  • HALO 4.74
  • KT 2.80
  • Revenue
  • HALO $1,242,852,000.00
  • KT $19,913,724,353.00
  • Revenue This Year
  • HALO $32.47
  • KT $6.62
  • Revenue Next Year
  • HALO $24.31
  • KT N/A
  • P/E Ratio
  • HALO $15.34
  • KT $12.13
  • Revenue Growth
  • HALO 31.19
  • KT 5.39
  • 52 Week Low
  • HALO $46.26
  • KT $15.49
  • 52 Week High
  • HALO $79.50
  • KT $21.61
  • Technical
  • Relative Strength Index (RSI)
  • HALO 63.53
  • KT 49.01
  • Support Level
  • HALO $68.09
  • KT $17.69
  • Resistance Level
  • HALO $70.81
  • KT $17.95
  • Average True Range (ATR)
  • HALO 2.26
  • KT 0.33
  • MACD
  • HALO 0.46
  • KT 0.05
  • Stochastic Oscillator
  • HALO 80.82
  • KT 81.62

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About KT KT Corporation

KT is South Korea's largest fixed-line telecom operator, with around 11.5 million fixed-line broadband customers and 9.5 million IPTV customers, and is the second-largest wireless operator with 28 million subscribers. Additionally, it has a number of nontelecom businesses, including real estate, payment processing, artificial intelligence, and IDC/cloud services, many of which are the focus of its growth strategy. The company was formed from the previously government-owned, monopoly telecom business and was listed in 1998. After selling its mobile business in 1994 (forming its mobile competitor, SK Telecom) KT created its own mobile operator in 1997.

Share on Social Networks: